Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |